好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Case series of hypertrophic pachymeningitis with underlying etiology
Autoimmune Neurology
Autoimmune Neurology Posters (7:00 AM-5:00 PM)
047
To highlight the spectrum of clinical phenotypes and etiologies in a case series of hypertrophic pachymeningitis patients. 

Hypertrophic pachymeningitis (HP) is a chronic inflammatory rare disorder characterized by fibrosis involving the intracranial and/or spinal cord  dura mater. 

Here we report two biopsy proven cases and the rest had imaging and csf findings suggestive of sarcoidosis


 
Retrospective chart review

Case 1: A 68-year-old female presents with a 2-year history of progressive bilateral ptosis and blurry vision as well as 6 months of diplopia found to have bilateral ptosis, upward gaze fatigability, and right CN VI palsy. MRI brain revealed diffuse pachymeningeal inflammation probable sarcoidosis, CSF ACE elevated at 3.1 U/L.


Case 2: A 48-year-old male with left
 episcleritis presents with a 2-year history of leg weakness and acute onset of headache and vertigo. MRI brain revealed pachymeningeal enhancement at the cerebral tentorium with repeat scan in January 2020 revealing diffuse pachymeningeal enhancement. Right temporal dural biopsy revealed necrotizing pachymeninges secondary to ANCA + vasculitis. 

 

Case 3: A 64-year-old-male develops new onset chronic daily headache, predominantly bifrontal and significant fatigue. MRI brain showed diffuse pachymeningeal thickening and enhancement. LP was normal with normal ACE level. We are currently awaiting biopsy for this patient with possibility of sarcoidosis. 

 

Case 4: A 37-year-old male  who at age 25 developed new onset intractable holocephalic, throbbing headache and seizures. He had extensive work up done prior to establishing with our practice which included left temporal lobe biopsy of a mass-like lesion which revealed Idiopathic Hypertrophic Pachymeningitis. Initially treated with Imuran and later switched to Rituximab.

 

Our case series highlights the wide spectrum of HP which can range from ANCA vasculitis to sarcoidosis. Distinction of various underlying cause is important to guide management
Authors/Disclosures
Maria Camila Moreno Escobar, MD (West Virginia University, rockefeller neuroscience institute)
PRESENTER
Dr. Moreno Escobar has nothing to disclose.
No disclosure on file
Michael Ebbert, MD (West Virginia University) Dr. Ebbert has nothing to disclose.
Ameneh Zare Shahabadi, MD, MPH Dr. Zare Shahabadi has nothing to disclose.
Shamima Akter, MD (West Virginia University) Dr. Akter has nothing to disclose.
Shitiz K. Sriwastava, MBBS (UT Health Houston) Dr. Sriwastava has nothing to disclose.